Poor adherence to medication regimens costs taxpayers $ Billions of each year. NexDose® announces launch of its new IT solution for improved adherence.
Coral Gables, FL (PRWeb)June 10, 2009 -- VivoNex, LLC announces the launch of its online NexDose® Medication Therapy Management System. The NexDose® system offers an opportunity to save billions of healthcare dollars by helping patients take medications properly.
The excess costs in the U.S. associated with patient non-adherence are estimated to be more than $100 Billion annually. In human terms, poor adherence contributes to more than 125,000 deaths from cardiac disease each year and is a major cause for admission to hospitals and nursing homes.
Comparing patient performance to prescribed instructions gives patients and healthcare providers a new platform for improving adherence through intervention and incentive programs.
More than 50% of prescribed medications are not taken properly. Although many factors contribute to poor adherence, the most common reason cited by patients is that they simply "sometimes forget."
The NexDose® system was designed with elements that have been shown to improve adherence. In a comprehensive review of the literature, it was determined that "Strategies that appear to have some effect on long term regimens involve a combination of counseling, reminders, self monitoring, feedback and supportive care" (Haynes, McDonald et al The Cochrine Data Base of Systematic Reviews Vol. 1 2005 Interventions for Helping Patients Follow Prescriptions for Medications). The NexDose® System supports this approach to improve adherence.
The NexDose® Digital Assistant reminds patients to take medication on time and monitors their performance; its user-friendly features were designed with extensive input from patients, physicians, researchers, and pharmacists. Connection of the digital assistant to the online database permits remote programming and gives healthcare providers access to patient adherence data. NexDose® online services encourage healthcare team collaboration and patient communication, thus enabling coordinated patient care.
The system provides many other benefits. To encourage participation of healthcare providers, registration for secure, online access to the patient's medication record is free of charge. System users are provided with a drug information database, tools for pinpointing patient non-adherence behaviors, and options to set adherence threshold levels, which are useful in patient management and incentive-based wellness programs.
In the current climate where the U.S. government is searching for approaches to improve healthcare quality and reduce overall cost, the NexDose® Medication Therapy Management System offers a promising option. In routine medical patients, the cost savings between adherent and non-adherent behaviors can rise to $4,000 per patient per year. With an annual cost under $200, NexDose® can provide a significant return on the health care dollar investment.
VivoNex, LLC looks forward to working with third party payers to improve patient adherence to medication therapy using NexDose®.
About VivoNex, LLC:
The failure of patients to use prescribed medications properly is a major health problem in the United States. It results in significant patient morbidity and mortality and creates a huge financial burden for the U.S. healthcare system. VivoNex, LLC was founded with the objective of building and implementing technological solutions designed to increase patient adherence with prescribed medication therapy.
For further information or demonstrations, contact:
Ronald Sekura, Ph.D, President and CEO
Read the full story at http://www.prweb.com/releases/NexDose/Medication_Reminder/prweb2511414.htm.
Copyright©2009 Vocus, Inc.
All rights reserved